# TRIBEAU

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tribeau

- Industry: Software
- Headquarters: Tokyo, Japan
- Website: https://corp.tribeau.jp
- Total disclosed funding: $8.6M
- Latest round: Series C (Jan 29, 2025)
- Investors on record: 6

## About

Based in Japan, TRIBEAU Inc. is engaged in providing innovative solutions within the medical aesthetics industry, focusing on cosmetic procedures, skincare products, and advanced treatment options that enhance skin health and appearance. TRIBEAU Inc. is a Tokyo-based company established in 2017, specializing in the medical aesthetics market. In January 2025, TRIBEAU Inc. raised an undisclosed amount in series C funding from new investors Nippon Venture Capital, and United, with participation from an unspecified investor. This round was part of a larger JPY 600 million equity and debt funding, bringing the total Series C funding to JPY 2.3 billion. Founded by individuals with a background in beauty technology, TRIBEAU has not reported any significant pivots in its operational strategy. Tribeau operates in the medical aesthetics industry, specializing in innovative solutions for cosmetic procedures. Their core offerings include a range of advanced skincare products and minimally invasive treatment options designed to enhance and rejuvenate skin appearance. Tribeau's products serve diverse use cases, such as addressing skin aging, improving complexion, and facilitating post-procedural care. These solutions cater primarily to dermatology clinics, cosmetic surgeons, and medical spa facilities, with a customer base comprising healthcare professionals and aesthetic practitioners across markets, including Japan, South Korea, and select regions in North America, where demand for aesthetic treatments is growing.Revenue generation at Tribeau is primarily driven through direct sales to medical clinics and aesthetic professionals, utilizing a B2B model. The company maintains structured pricing plans for its flagship products, which include proprietary skincare lines and treatment devices tailored to the needs of practitioners and their clientele. Transactions typically occur through bulk orders or subscription agreements that allow clinics to replenish their inventory regularly. Pricing strategies are designed to accommodate varying scales of practice, ensuring that both small clinics and larger medical chains can access their offerings. The January 2025 venture debt and series C funding will enable TRIBEAU Inc. to invest in marketing and technology enhancements, integrate with external systems to support beauty clinic operations, and hire new employees across key business functions by the end of 2025. Additionally, TRIBEAU aims to expand its presence in Southeast Asia and North America by mid-2025 to capitalize on growing demand in these regions.

## Funding rounds

- Series C, Jan 29, 2025 — Nippon Venture Capital, UNITED, inc.
- Series B, Feb 1, 2022, $8.6M — KDDI, Mitsubishi UFJ Capital, Nissay Capital, W

## Investors

- KDDI — Series B
- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series B
- Nissay Capital (https://capitalatlas.ai/funds/nissay-capital) — Series B
- W (https://capitalatlas.ai/funds/w) — Series B
- Nippon Venture Capital (https://capitalatlas.ai/funds/nippon-venture-capital) — Series C
- UNITED, inc. — Series C